Supplement: The Role of B Cells in Rheumatoid Arthritis

1 For example, indicators of RA include the presence of rheumatoid factor (RF) and antibodies against citrullinated peptides (anti-CCP), which point toward a central role of activated B cells and plasma cells producing autoreactive immunoglobulin. In the last few years, basic and clinical research have shown that B cells can affect RA in many ways. In affected tissues of autoimmune patients, lymphoid follicles with germinal centers (GCs) - the so-called tertiary lymphoid structures - fr

Written byThomas Dörner
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In affected tissues of autoimmune patients, lymphoid follicles with germinal centers (GCs) - the so-called tertiary lymphoid structures - frequently form. This clearly indicates B-cell activation and differentiation into plasma cells and memory B cells. These aggregates - T cells surrounding CD20 + B cells - form GC-like structures in patients with RA or other autoimmune diseases. Moreover, Seisuke Takemura of the Mayo Clinic and colleagues demonstrated in mice that T-cell activation in RA is B-cell dependent. 2 Treatment with B cell-depleting antibodies destroyed the extrafollicular GCs, removed dendritic follicular cell networks, and disrupted T-cell activation.

In autoimmunity, B cells participate in various processes. 3 For instance, B cells produce proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), and IL-6. On the other hand, B cells produce IL-10, which inhibits inflammation.

B cells also make autoantibodies that can trigger autoimmunity. Patients with RA, for example, often exhibit autoantibodies ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies